Neogen | NEOG - Sales Revenues

Stock Price
8.19
Daily Change
-0.24 -2.85%
Monthly
-11.36%
Yearly
23.90%
Q2 Forecast
8.03

Neogen reported $211.2M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
Avanos Medical USD 182.2M 1.3M Mar/2026
Bio-Rad Laboratories USD 592.1M 101.1M Mar/2026
Cerus USD 50.81M 4.79M Dec/2024
Danaher USD 5.95B 890M Mar/2026
Idexx Laboratories USD 1.14B 50M Mar/2026
Illumina USD 1.09B 70M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quidel USD 620M 104M Mar/2026
Rockwell Medical USD 25.83M 3.15M Jun/2024
STAAR Surgical USD 93.5M 145.9M Mar/2026
Surmodics USD 29.57M 355K Jun/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Utah Medical Products USD 9.04M 955K Dec/2025
Zoetis USD 2.3B 100M Mar/2026